Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 6 (2009), Issue 7 (July)

1. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma.
   J Natl Cancer Inst, 101(13): 938-45. [Abstract] [Full-text]
2. Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib.
   Dtsch Med Wochenschr, 134(28): e1-2, 1464-6. [Abstract] [Full-text]
3. Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi.
   J Cell Physiol, 220(3): 640-54. [Abstract] [Full-text]
4. Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck.
   Lancet Oncol, 10(7): 700-8. [Abstract] [Full-text]
5. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.
   Cancer Cell, 16(1): 55-66. [Abstract] [Full-text]
6. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
   J Comp Pathol, 141(2): 89-97. [Abstract] [Full-text]
7. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
   J Clin Endocrinol Metab, 94(7): 2226-31. [Abstract] [Full-text]
8. Cutaneous malignant peripheral nerve sheath tumors.
   J Cutan Pathol, 36(8): 896-900. [Abstract] [Full-text]
9. Castleman's disease with numerous mantle zone lymphocytes with clear cytoplasm involving the skin: case report.
   J Cutan Pathol, 36(8): 887-91. [Abstract] [Full-text]
10. Apocrine mixed tumor of the skin with a prominent pilomatricomal component.
    J Cutan Pathol, 36(8): 882-6. [Abstract] [Full-text]
11. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.
    J Cutan Pathol, 36(8): 878-81. [Abstract] [Full-text]
12. Intravascular large B-cell lymphoma with cutaneous manifestations: a clinicopathologic, immunophenotypic and molecular study of three cases.
    J Cutan Pathol, 36(8): 865-70. [Abstract] [Full-text]
13. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    J Cutan Pathol, 36(8): 859-64. [Abstract] [Full-text]
14. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
    J Cutan Pathol, 36(8): 845-52. [Abstract] [Full-text]
15. Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.
    Toxicology, 262(2): 162-70. [Abstract] [Full-text]
16. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
    Life Sci, 85(5): 196-205. [Abstract] [Full-text]
17. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Dermatol Surg, 35(7): 1050-6. [Abstract] [Full-text]
18. Patient satisfaction after treatment of nonmelanoma skin cancer.
    Dermatol Surg, 35(7): 1041-9. [Abstract] [Full-text]
19. Immunohistochemical stains in Mohs surgery: a review.
    Dermatol Surg, 35(7): 1023-34. [Abstract] [Full-text]
20. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway.
    Cancer Lett, 282(2): 167-76. [Abstract] [Full-text]
21. Protein kinase Cepsilon reveals importance of extrinsic apoptosis in preventing UV carcinogenesis.
    J Invest Dermatol, 129(8): 1853-6. [Abstract] [Full-text]
22. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.
    J Invest Dermatol, 129(8): 1972-82. [Abstract] [Full-text]
23. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.
    Lasers Surg Med, 41(6): 417-22. [Abstract] [Full-text]
24. Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.
    Mol Carcinog, 48(8): 713-23. [Abstract] [Full-text]
25. Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant.
    Pediatr Transplant, 13(5): 628-31. [Abstract] [Full-text]
26. Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.
    Melanoma Res, 19(4): 243-51. [Abstract] [Full-text]
27. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Melanoma Res, 19(4): 226-37. [Abstract] [Full-text]
28. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Melanoma Res, 19(4): 211-4. [Abstract] [Full-text]
29. Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine.
    Melanoma Res, 19(4): 271-3. [Abstract] [Full-text]
30. Multiple melanoma arising on a burn scar and extensive sunburn: a case report and a review of the literature.
    Melanoma Res, 19(4): 195-8. [Abstract] [Full-text]
31. The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado.
    Melanoma Res, 19(4): 252-9. [Abstract] [Full-text]
32. GP-led melanoma follow-up: the practical experience of GPs.
    Fam Pract, 26(4): 317-24. [Abstract] [Full-text]
33. Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study.
    Melanoma Res, 19(4): 260-6. [Abstract] [Full-text]
34. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Melanoma Res, 19(4): 215-25. [Abstract] [Full-text]
35. Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
    Melanoma Res, 19(4): 238-42. [Abstract] [Full-text]
36. Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patients.
    Melanoma Res, 19(4): 199-202. [Abstract] [Full-text]
37. Improved survival for stage IV melanoma from an unknown primary site.
    J Clin Oncol, 27(21): 3489-95. [Abstract] [Full-text]
38. Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
    J Clin Oncol, 27(21): 3496-502. [Abstract] [Full-text]
39. Digital image referral for suspected skin malignancy--a pilot study of 300 patients.
    J Plast Reconstr Aesthet Surg, 62(8): 1048-53. [Abstract] [Full-text]
40. Digital epiluminescence dermoscopy for pigmented cutaneous lesions, primary care physicians, and telediagnosis: a useful tool?
    J Plast Reconstr Aesthet Surg, 62(8): 1054-8. [Abstract] [Full-text]
41. Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma.
    J Plast Reconstr Aesthet Surg, 62(8): 1063-7. [Abstract] [Full-text]
42. Patient satisfaction with receiving skin cancer diagnosis by letter: comparison with face-to-face consultation.
    J Plast Reconstr Aesthet Surg, 62(8): 1059-62. [Abstract] [Full-text]
43. Melanoma recurrence confined to a free flap after isolated limb perfusion.
    J Plast Reconstr Aesthet Surg, 62(8): e277-9. [Abstract] [Full-text]
44. Carcinoma cunniculatum on the shoulder: an atypical localisation of a verrucous carcinoma.
    J Plast Reconstr Aesthet Surg, 62(8): e267-9. [Abstract] [Full-text]
45. Delayed presentation of tattoo lymphadenopathy mimicking malignant melanoma lymphadenopathy.
    J Plast Reconstr Aesthet Surg, 62(8): e283-5. [Abstract] [Full-text]
46. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    J Am Acad Dermatol, 61(2): 348-55. [Abstract] [Full-text]
47. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40.
    J Am Acad Dermatol, 61(2): 276-80. [Abstract] [Full-text]
48. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    J Am Acad Dermatol, 61(2): 263-70. [Abstract] [Full-text]
49. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    J Am Acad Dermatol, 61(2): 271-5. [Abstract] [Full-text]
50. Development of a two-step method for the diagnosis of melanoma by reflectance confocal microscopy.
    J Am Acad Dermatol, 61(2): 216-29. [Abstract] [Full-text]
51. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
    J Am Acad Dermatol, 61(2): 207-15. [Abstract] [Full-text]
52. The significance of reflectance confocal microscopy in the assessment of solitary pink skin lesions.
    J Am Acad Dermatol, 61(2): 230-41. [Abstract] [Full-text]
53. Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy.
    J Am Acad Dermatol, 61(2): 341-5. [Abstract] [Full-text]
54. Melanoma arising in segmental nevus spilus: detection by sequential digital dermatoscopy.
    J Am Acad Dermatol, 61(2): 337-41. [Abstract] [Full-text]
55. Biomarkers in melanoma.
    Ann Oncol, 20: vi8-13. [Abstract] [Full-text]
56. A systematic review of health-related quality of life in cutaneous melanoma.
    Ann Oncol, 20: vi51-8. [Abstract] [Full-text]
57. Immunotherapy of distant metastatic disease.
    Ann Oncol, 20: vi41-50. [Abstract] [Full-text]
58. Small molecules and targeted therapies in distant metastatic disease.
    Ann Oncol, 20: vi35-40. [Abstract] [Full-text]
59. Utility of adjuvant systemic therapy in melanoma.
    Ann Oncol, 20: vi30-4. [Abstract] [Full-text]
60. Surgery and radiotherapy in the treatment of cutaneous melanoma.
    Ann Oncol, 20: vi22-9. [Abstract] [Full-text]
61. Staging of cutaneous melanoma.
    Ann Oncol, 20: vi14-21. [Abstract] [Full-text]
62. Epidemiology of invasive cutaneous melanoma.
    Ann Oncol, 20: vi1-7. [Abstract] [Full-text]
63. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines.
    Ultrasound Med Biol, 35(8): 1397-404. [Abstract] [Full-text]
64. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi.
    Arch Dermatol, 145(7): 816-26. [Abstract] [Full-text]
65. Fatal cytotoxic cutaneous lymphoma presenting as ulcerative psoriasis.
    Arch Dermatol, 145(7): 801-8. [Abstract] [Full-text]
66. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.
    Arch Dermatol, 145(7): 792-6. [Abstract] [Full-text]
67. Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses.
    Arch Dermatol, 145(7): 766-72. [Abstract] [Full-text]
68. Efficacy of diagnostic ultrasonography of lipomas, epidermal cysts, and ganglions.
    Arch Dermatol, 145(7): 761-4. [Abstract] [Full-text]
69. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.
    Int J Cancer, 125(6): 1250-6. [Abstract] [Full-text]
70. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
    Int J Cancer, 125(6): 1243-9. [Abstract] [Full-text]
71. Carcinoid-like pattern in melanoma: report of 4 cases.
    Am J Dermatopathol, 31(6): 542-50. [Abstract] [Full-text]
72. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
    Am J Dermatopathol, 31(6): 557-60. [Abstract] [Full-text]
73. Viral-associated nonmelanoma skin cancers: a review.
    Am J Dermatopathol, 31(6): 561-73. [Abstract] [Full-text]
74. Dermatoscopy of a primary dermal melanoma.
    Am J Dermatopathol, 31(6): 574-7. [Abstract] [Full-text]
75. Low-grade B-cell proliferation progressing to high-grade B-cell lymphoma.
    Am J Dermatopathol, 31(6): 578-81. [Abstract] [Full-text]
76. Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma.
    Am J Dermatopathol, 31(6): 587-90. [Abstract] [Full-text]
77. Spiradenocylindrocarcinoma. Report of a case with a low-grade component of spiradenocarcinoma and an immunohistochemical study.
    Am J Dermatopathol, 31(6): 594-8. [Abstract] [Full-text]
78. A rare case of a cutaneous squamomelanocytic tumor: revisiting the histogenesis of combined neoplasms.
    Am J Dermatopathol, 31(6): 599-603. [Abstract] [Full-text]
79. An update on lasers in children.
    Curr Opin Pediatr, 21(4): 499-504. [Abstract] [Full-text]
80. Optical transfer diagnosis of pigmented lesions: a pilot study.
    Skin Res Technol, 15(3): 330-7. [Abstract] [Full-text]
81. Approximate lesion localization in dermoscopy images.
    Skin Res Technol, 15(3): 314-22. [Abstract] [Full-text]
82. Detection of basal cell carcinoma using color and histogram measures of semitranslucent areas.
    Skin Res Technol, 15(3): 283-7. [Abstract] [Full-text]
83. Obtaining malignant melanoma indicators through statistical analysis of 3D skin surface disruptions.
    Skin Res Technol, 15(3): 262-70. [Abstract] [Full-text]
84. Expanded narrow subcutaneous-pedicled island forehead flap for reconstruction of the forehead.
    Ann Plast Surg, 63(2): 167-70. [Abstract] [Full-text]
85. Zebrafish embryo extracts promote sphere-forming abilities of human melanoma cell line.
    Cancer Sci, 100(8): 1429-33. [Abstract] [Full-text]
86. Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.
    Cancer Immunol Immunother, 58(10): 1635-46. [Abstract] [Full-text]
87. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
    Scand J Immunol, 70(2): 85-92. [Abstract] [Full-text]
88. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
    Am J Surg Pathol, 33(8): 1146-56. [Abstract] [Full-text]
89. Pediatric melanoma: a single-institution experience of 150 patients.
    J Pediatr Surg, 44(8): 1514-21. [Abstract] [Full-text]
90. Therapeutic vaccines in solid tumours: can they be harmful?
    Eur J Cancer, 45(12): 2087-90. [Abstract] [Full-text]
91. Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer.
    Eur J Cancer, 45(12): 2207-11. [Abstract] [Full-text]
92. Web-based resources for sun protection information--a French-language evaluation.
    Eur J Cancer, 45(12): 2160-7. [Abstract] [Full-text]
93. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
    Nat Genet, 41(8): 915-9. [Abstract] [Full-text]
94. New common variants affecting susceptibility to basal cell carcinoma.
    Nat Genet, 41(8): 909-14. [Abstract] [Full-text]
95. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model.
    Carcinogenesis, 30(8): 1408-15. [Abstract] [Full-text]
96. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.
    Cancer Res, 69(15): 6158-63. [Abstract] [Full-text]
97. Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.
    Cancer Res, 69(15): 6265-74. [Abstract] [Full-text]
98. Radioactive treatment of a murine melanoma using a (32)P-patch.
    Nucl Med Commun, 30(9): 706-12. [Abstract] [Full-text]
99. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
    Mod Pathol, 22(8): 989-95. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.